isoflavanone has been researched along with daunorubicin in 1 studies
| Studies (isoflavanone) | Trials (isoflavanone) | Recent Studies (post-2010) (isoflavanone) | Studies (daunorubicin) | Trials (daunorubicin) | Recent Studies (post-2010) (daunorubicin) |
|---|---|---|---|---|---|
| 94 | 5 | 39 | 8,239 | 886 | 1,310 |
| Protein | Taxonomy | isoflavanone (IC50) | daunorubicin (IC50) |
|---|---|---|---|
| 72 kDa type IV collagenase | Homo sapiens (human) | 1.9 | |
| Multidrug resistance-associated protein 1 | Homo sapiens (human) | 8 | |
| Histone deacetylase 1 | Homo sapiens (human) | 0.047 | |
| Histone deacetylase 8 | Homo sapiens (human) | 0.22 | |
| Histone deacetylase 6 | Homo sapiens (human) | 0.02 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gayer, B; Knoll, E; Kohen, F; Kulik, T; Sharon, O; Somjen, D; Stern, N | 1 |
1 other study(ies) available for isoflavanone and daunorubicin
| Article | Year |
|---|---|
Carboxy derivatives of isoflavones as affinity carriers for cytotoxic drug targeting in adrenocortical H295R carcinoma cells.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Animals; Antibiotics, Antineoplastic; Cell Survival; Creatine Kinase; Daunorubicin; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Estrogens; Female; Humans; Isoflavones; Neoplasm Proteins; Rats; Rats, Wistar; Receptors, Estrogen; Transcription, Genetic; Tumor Cells, Cultured | 2003 |